Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Cyanotech (CYAN) Competitors

Cyanotech logo

CYAN vs. IMCC, AKAN, BON, SMFL, CRON, CDXC, USNA, TLRY, MNMD, and SNDL

Should you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include IM Cannabis (IMCC), Akanda (AKAN), Bon Natural Life (BON), Smart for Life (SMFL), Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), Tilray (TLRY), Mind Medicine (MindMed) (MNMD), and SNDL (SNDL). These companies are all part of the "medicinals & botanicals" industry.

Cyanotech vs.

Cyanotech (NASDAQ:CYAN) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Cyanotech has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.

24.4% of Cyanotech shares are owned by institutional investors. Comparatively, 7.7% of IM Cannabis shares are owned by institutional investors. 29.1% of Cyanotech shares are owned by company insiders. Comparatively, 5.9% of IM Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, IM Cannabis had 3 more articles in the media than Cyanotech. MarketBeat recorded 3 mentions for IM Cannabis and 0 mentions for Cyanotech. IM Cannabis' average media sentiment score of 0.63 beat Cyanotech's score of 0.00 indicating that IM Cannabis is being referred to more favorably in the news media.

Company Overall Sentiment
Cyanotech Neutral
IM Cannabis Positive

Cyanotech has higher earnings, but lower revenue than IM Cannabis. Cyanotech is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cyanotech$23.07M0.13-$5.27M-$0.66-0.64
IM Cannabis$54.03M0.07-$7.04M-$2.56-0.63

Cyanotech has a net margin of -19.50% compared to IM Cannabis' net margin of -25.55%. Cyanotech's return on equity of -44.71% beat IM Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Cyanotech-19.50% -44.71% -19.12%
IM Cannabis -25.55%-129.86%-23.63%

Cyanotech received 122 more outperform votes than IM Cannabis when rated by MarketBeat users. Likewise, 63.68% of users gave Cyanotech an outperform vote while only 42.86% of users gave IM Cannabis an outperform vote.

CompanyUnderperformOutperform
CyanotechOutperform Votes
128
63.68%
Underperform Votes
73
36.32%
IM CannabisOutperform Votes
6
42.86%
Underperform Votes
8
57.14%

Summary

Cyanotech beats IM Cannabis on 10 of the 15 factors compared between the two stocks.

Get Cyanotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYAN vs. The Competition

MetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$3.01M$1.22B$5.45B$8.30B
Dividend YieldN/AN/A5.44%4.20%
P/E Ratio-0.6411.4625.6919.66
Price / Sales0.138.83410.10116.75
Price / CashN/A10.4038.3134.62
Price / Book0.321.466.744.46
Net Income-$5.27M-$56.07M$3.23B$248.29M

Cyanotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYAN
Cyanotech
N/A$0.42
flat
N/A+44.6%$3.01M$23.07M-0.6495
IMCC
IM Cannabis
0.3722 of 5 stars
$1.48
+4.2%
N/A-61.6%$3.30M$54.03M-0.43340Upcoming Earnings
AKAN
Akanda
N/A$1.15
flat
N/A-85.2%$1.64M$2.51M0.00110Gap Down
BON
Bon Natural Life
N/A$0.07
+13.2%
N/A-98.0%$271,000.00$23.84M0.00100Positive News
Gap Up
High Trading Volume
SMFL
Smart for Life
N/A$0.00
+233.3%
N/A-100.0%$7,000.00$11.11M0.00110Gap Down
CRON
Cronos Group
1.4891 of 5 stars
$1.83
+1.7%
$3.50
+91.3%
-28.5%$659.05M$117.62M-14.08450Earnings Report
CDXC
ChromaDex
2.9031 of 5 stars
N/A$9.03
+∞
N/A$611.50M$99.60M787.29120
USNA
USANA Health Sciences
4.4037 of 5 stars
$27.47
+1.1%
$36.00
+31.1%
-36.8%$518.08M$876.24M9.711,900Insider Trade
Positive News
TLRY
Tilray
1.5069 of 5 stars
$0.48
-2.1%
$1.92
+301.9%
-77.9%$480.00M$210.48M-1.592,650Gap Up
MNMD
Mind Medicine (MindMed)
2.2856 of 5 stars
$6.36
+2.1%
$25.11
+294.8%
-33.5%$479.34MN/A-2.8140Earnings Report
Analyst Forecast
News Coverage
Gap Up
SNDL
SNDL
2.6109 of 5 stars
$1.47
-1.3%
$3.63
+146.6%
-43.9%$386.28M$920.45M-4.74580Gap Up

Related Companies and Tools


This page (NASDAQ:CYAN) was last updated on 5/12/2025 by MarketBeat.com Staff
From Our Partners